Explore 3 Stock Ideas & Industry Insights Download Free Report

Owens & Minor Inc

Healthcare US OMI

NoneUSD
0.00(0%)

Last update at 2026-04-09T21:02:37.346609Z

Day Range

--
LowHigh

52 Week Range

11.7923.66
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap1545.32M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield0.05%
  • EBITDA358.88M
  • Revenue TTM10228.92M
  • Revenue Per Share TTM135.51
  • Gross Profit TTM 1826.35M
  • Diluted EPS TTM-1.56

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 10.89M 276.75M 109.91M -28.71900M -469.19500M
Minority interest - - - - -
Net income 22.39M 221.59M 88.07M -22.58400M -437.01200M
Selling general administrative 1633.67M 1116.87M 1041.32M 1023.05M 1261.75M
Selling and marketing expenses 1633.67M - 0.01M 0.01M -
Gross profit 1826.35M 1513.23M 1280.83M 1128.49M 1366.96M
Reconciled depreciation 228.67M 90.62M 93.34M 116.68M 101.93M
Ebit 194.80M 368.47M 204.12M 99.44M 109.64M
Ebitda 423.47M 489.97M 324.39M 216.12M 211.57M
Depreciation and amortization 228.67M 121.50M 120.28M 116.68M 101.93M
Non operating income net other - -43.62900M -10.81200M -3.75700M -
Operating income 194.80M 368.47M 204.12M 99.44M -392.17400M
Other operating expenses 9757.54M 9382.77M 8238.31M 9107.74M 9729.07M
Interest expense 128.89M 48.09M 83.40M 98.11M 77.02M
Tax provision -11.49800M 55.16M 21.83M -6.13500M -32.18300M
Interest income 128.89M 48.09M 83.40M 98.11M 70.98M
Net interest income -128.89100M -48.09000M -83.39800M -98.11300M -77.02100M
Extraordinary items 0.00000M 0.00000M -58.20300M -39.78700M -42.34700M
Non recurring - 34.08M 37.75M 30.05M 501.81M
Other items - - - - -
Income tax expense -11.49800M 55.16M 21.83M -6.13500M -32.18300M
Total revenue 9955.48M 9785.32M 8480.18M 9210.94M 9838.71M
Total operating expenses 1628.42M 1110.68M 1038.96M 1025.29M 1257.32M
Cost of revenue 8129.12M 8272.09M 7199.34M 8082.45M 8471.75M
Total other income expense net -183.91300M -91.71900M -94.21000M -128.16300M -501.81300M
Discontinued operations - - -58.20300M -39.78700M -42.34700M
Net income from continuing ops 22.39M 221.59M 88.07M -34.85400M -501.37800M
Net income applicable to common shares 22.39M 221.59M 29.87M -62.37100M -437.01200M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 5386.28M 3536.55M 3335.64M 3643.08M 3773.79M
Intangible assets 445.04M 209.75M 243.35M 285.02M 321.76M
Earning assets - - - - -
Other current assets 128.64M 88.56M 118.26M 79.37M 321.69M
Total liab 4440.68M 2598.05M 2623.59M 3180.93M 3255.37M
Total stockholder equity 945.60M 938.50M 712.05M 462.15M 518.42M
Deferred long term liab - 35.31M 50.64M 40.55M 50.85M
Other current liab 419.05M 342.06M 345.54M 608.12M 362.42M
Common stock 152.56M 150.87M 146.94M 125.69M 124.59M
Capital stock 152.56M 150.87M 146.94M 125.69M 124.59M
Retained earnings 410.01M 387.62M 167.02M 137.77M 200.67M
Other liab 175.78M 144.25M 171.91M 121.84M 128.56M
Good will 1636.70M 390.19M 394.09M 393.18M 414.12M
Other assets 150.42M 103.57M 246.68M 56.36M 136.07M
Cash 69.47M 55.71M 83.06M 67.03M 103.37M
Cash and equivalents 69.47M 55.71M 83.06M 67.03M 103.37M
Total current liabilities 1566.47M 1344.02M 1345.73M 1416.16M 1472.01M
Current deferred revenue - 28.30M - - -
Net debt 2628.97M 1054.07M 1022.89M 1558.46M 1547.21M
Short term debt 0.00000M 96.33M 4.10M 50.22M 28.69M
Short long term debt - - - 50.22M 28.69M
Short long term debt total 2698.44M 1109.78M 1105.95M 1625.49M 1650.58M
Other stockholder equity 418.89M 440.61M 436.60M 251.40M 238.77M
Property plant equipment 858.93M 511.24M 460.42M 315.43M 386.72M
Total current assets 2295.18M 2321.81M 2135.86M 2407.28M 2538.58M
Long term investments - - - - -
Net tangible assets -1174.84300M 338.57M 74.62M -216.04500M -217.46700M
Short term investments - - - - -
Net receivables 763.50M 681.56M 700.79M 674.71M 823.42M
Long term debt 2482.97M 947.54M 986.02M 1508.41M 1650.58M
Inventory 1333.59M 1495.97M 1233.75M 1146.19M 1290.10M
Accounts payable 1147.41M 1001.96M 1000.19M 808.03M 1109.59M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -35.85500M -40.59100M -38.50900M -52.70700M -45.61200M
Additional paid in capital - - - - -
Common stock total equity - 150.87M 146.94M 125.69M 124.59M
Preferred stock total equity - - - - -
Retained earnings total equity - 387.62M 167.02M 137.77M 200.67M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 150.42M 103.57M 101.92M 99.96M 112.60M
Deferred long term asset charges - - - - -
Non current assets total 3091.10M 1214.74M 1199.77M 1235.80M 1235.21M
Capital lease obligations 215.47M 162.24M 119.93M 117.08M -
Long term debt total 2482.97M 947.54M 986.02M 1508.41M 1650.58M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1804.47600M -53.63000M 80.07M -51.89700M -815.82900M
Change to liabilities 13.65M 3.55M 193.24M -235.63100M 92.18M
Total cashflows from investing activities -1804.47600M -53.63000M 80.07M -51.89700M -815.82900M
Net borrowings 1582.50M -110.78600M -547.23800M -32.20000M 695.75M
Total cash from financing activities 1497.11M -129.47800M -379.38600M -130.19700M 701.07M
Change to operating activities -91.54400M 0.69M 5.28M 104.80M -23.60400M
Net income 22.39M 221.59M 29.87M -62.37100M -437.01200M
Change in cash 14.15M -62.47100M 49.82M -18.68000M -1.15500M
Begin period cash flow 72.03M 134.51M 84.69M 103.37M 104.52M
End period cash flow 86.19M 72.03M 134.51M 84.69M 103.37M
Total cash from operating activities 325.01M 124.18M 339.22M 166.09M 115.59M
Issuance of capital stock 0.00000M 0.00000M 189.97M - -
Depreciation 228.67M 90.62M 93.34M 116.68M 101.93M
Other cashflows from investing activities -1637.89400M -12.64500M 130.50M -9.47800M -770.95600M
Dividends paid 0.00000M -0.73100M -0.64800M -5.22600M 48.20M
Change to inventory 166.56M -263.43900M -85.15400M 127.92M -65.45100M
Change to account receivables 1.10M -2.20100M -34.81800M 63.53M 11.11M
Sale purchase of stock 0.00000M 0.00000M 144.73M - 0.00000M
Other cashflows from financing activities 2657.91M 527.59M -16.49100M -7.17900M 765.52M
Change to netincome -15.81800M 71.90M 139.15M 15.80M 16.38M
Capital expenditures 166.58M 49.69M 59.19M 52.23M 65.69M
Change receivables - -2.20100M -34.81800M -63.52600M -11.10600M
Cash flows other operating - 2.15M 3.60M -104.80100M 23.60M
Exchange rate changes - - - - -1.98600M
Cash and cash equivalents changes - -58.93100M 39.91M -16.00900M -1.15500M
Change in working capital 89.77M -261.40000M 78.55M 60.62M 14.23M
Stock based compensation 20.99M 25.02M 20.01M 15.80M 16.38M
Other non cash items -10.45000M 78.09M 101.90M 52.76M 455.09M
Free cash flow 158.42M 74.49M 280.03M 113.86M 49.90M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OMI
Owens & Minor Inc
- -% - - 10.62 0.15 1.74 0.36 13.07
COR
Cencora Inc.
6.68 2.53% 270.32 37.46 17.70 0.19 31.84 0.20 17.10
MCK
McKesson Corporation
17.42 2.36% 756.95 17.95 14.53 0.20 5.04 0.22 12.17
CAH
Cardinal Health Inc
5.89 3.01% 201.74 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc
0.56 0.74% 76.30 24.12 14.04 0.74 2.50 0.95 13.33

Reports Covered

Stock Research & News

Profile

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.

Owens & Minor Inc

9120 Lockwood Boulevard, Mechanicsville, VA, United States, 23116

Key Executives

Name Title Year Born
Mr. Edward A. Pesicka Pres, CEO & Director 1968
Mr. Nicholas Joseph Pace II Exec. VP, Gen. Counsel & Corp. Sec. 1971
Mr. Andrew G. Long Exec. VP and CEO of Products & Healthcare Services Segment 1965
Mr. Alexander J. Bruni Exec. VP & CFO 1976
Mr. Michael Wayne Lowry Sr. VP, Corp. Controller & Chief Accounting Officer 1962
Alex Jost CPA Director of Investor Relations NA
Ms. Tammy Gomez Exec. VP & Chief HR Officer NA
Mr. David Myers Sr. VP & Chief Procurement Officer NA
Mr. Jonathan A. Leon Sr. VP & Corp. Treasurer 1967
Mr. Daniel J. Starck Exec. VP, Pres of Patient Direct & CEO of Apria 1967

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.